RhumbLine Advisers’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $298K | Buy |
|
|||||
|
2020
Q3 | $288K | Sell |
|
|||||
|
2020
Q2 | $268K | Buy |
|
|||||
|
2020
Q1 | $281K | Buy |
|
|||||
|
2019
Q4 | $275K | Buy |
|
|||||
|
2019
Q3 | $245K | Sell |
|
|||||
|
2019
Q2 | $282K | Buy |
|
|||||
|
2019
Q1 | $259K | Sell |
|
|||||
|
2018
Q4 | $272K | Buy |
|
|||||
|
2018
Q3 | $187K | Sell |
|
|||||
|
2018
Q2 | $208K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $149K | Buy |
|
|||||
|
2016
Q4 | $158K | Sell |
|
|||||
|
2016
Q3 | $212K | Buy |
|
|||||
|
2016
Q2 | $173K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $200K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $291K | Buy |
|